AAAAAA

   
Results: 1-24 |
Results: 24
METHOTREXATE TREATMENT FOR CROHNS-DISEASE
Authors: FEAGAN BG
Citation: Bg. Feagan, METHOTREXATE TREATMENT FOR CROHNS-DISEASE, Inflammatory bowel diseases, 4(2), 1998, pp. 120-121
AN EVALUATION OF UTILITY MEASUREMENT IN GASTROESOPHAGEAL REFLUX DISEASE (GERD)
Authors: ETHIOPIA A GREGOR JC PREIKSAITIS HG REYNOLDS RPG FEAGAN BG
Citation: A. Ethiopia et al., AN EVALUATION OF UTILITY MEASUREMENT IN GASTROESOPHAGEAL REFLUX DISEASE (GERD), Gastroenterology, 114(4), 1998, pp. 477-477
PHYSICIANS PERCEPTION OF UTILITY IN CROHNS-DISEASE
Authors: MYERS R PANACCIONE R GREGOR J FEAGAN BG
Citation: R. Myers et al., PHYSICIANS PERCEPTION OF UTILITY IN CROHNS-DISEASE, Gastroenterology, 114(4), 1998, pp. 4285-4285
AN EVALUATION OF UTILITY MEASUREMENT IN CROHNS-DISEASE
Authors: GREGOR JC MCDONALD JWD KLAR N WALL R ATKINSON K LAMBA B FEAGAN BG
Citation: Jc. Gregor et al., AN EVALUATION OF UTILITY MEASUREMENT IN CROHNS-DISEASE, Inflammatory bowel diseases, 3(4), 1997, pp. 265-276
METHOTREXATE FOR ULCERATIVE-COLITIS - DISCOURAGING NEWS - COMMENT
Authors: FEAGAN BG
Citation: Bg. Feagan, METHOTREXATE FOR ULCERATIVE-COLITIS - DISCOURAGING NEWS - COMMENT, Inflammatory bowel diseases, 3(2), 1997, pp. 178-179
A RANDOMIZED STUDY COMPARING A PATIENT DIRECTED HYPERTENSION MANAGEMENT STRATEGY WITH USUAL OFFICE-BASED CARE
Authors: ZARNKE KB FEAGAN BG MAHON JL FELDMAN RD
Citation: Kb. Zarnke et al., A RANDOMIZED STUDY COMPARING A PATIENT DIRECTED HYPERTENSION MANAGEMENT STRATEGY WITH USUAL OFFICE-BASED CARE, American journal of hypertension, 10(1), 1997, pp. 58-67
A RANDOMIZED STUDY COMPARING A PATIENT DIRECTED HYPERTENSION MANAGEMENT STRATEGY WITH USUAL OFFICE-BASED CARE
Authors: ZARNKE KB FEAGAN BG MAHON JL FELDMAN RD
Citation: Kb. Zarnke et al., A RANDOMIZED STUDY COMPARING A PATIENT DIRECTED HYPERTENSION MANAGEMENT STRATEGY WITH USUAL OFFICE-BASED CARE, American journal of hypertension, 10(1), 1997, pp. 58-67
INTRAVENOUS CYCLOSPORINE FOR SEVERE ATTACKS OF ULCERATIVE-COLITIS - ASURVEY OF CANADIAN GASTROENTEROLOGISTS
Authors: ATKINSON KA MCDONALD JWD LAMBA B FEAGAN BG
Citation: Ka. Atkinson et al., INTRAVENOUS CYCLOSPORINE FOR SEVERE ATTACKS OF ULCERATIVE-COLITIS - ASURVEY OF CANADIAN GASTROENTEROLOGISTS, Canadian journal of gastroenterology, 11(7), 1997, pp. 583-587
DRUG DEVELOPMENT IN INFLAMMATORY BOWEL-DISEASE - BUDESONIDE - A MODELOF TARGETED THERAPY
Authors: HAMEDANI R FELDMAN RD FEAGAN BG
Citation: R. Hamedani et al., DRUG DEVELOPMENT IN INFLAMMATORY BOWEL-DISEASE - BUDESONIDE - A MODELOF TARGETED THERAPY, Alimentary pharmacology & therapeutics, 11, 1997, pp. 98-107
MEDICAL THERAPY FOR INFLAMMATORY BOWEL-DISEASE
Authors: FEAGAN BG MCDONALD JWD
Citation: Bg. Feagan et Jwd. Mcdonald, MEDICAL THERAPY FOR INFLAMMATORY BOWEL-DISEASE, Current opinion in gastroenterology, 13(4), 1997, pp. 307-311
CYCLOSPORINE IN CROHNS-DISEASE
Authors: FEAGAN BG MCDONALD JW
Citation: Bg. Feagan et Jw. Mcdonald, CYCLOSPORINE IN CROHNS-DISEASE, Lancet, 349(9061), 1997, pp. 1328-1328
METHOTREXATE THERAPY FOR CHRONIC SARCOIDOSIS - IS THE THERAPEUTIC INDEX ACCEPTABLE
Authors: FEAGAN BG
Citation: Bg. Feagan, METHOTREXATE THERAPY FOR CHRONIC SARCOIDOSIS - IS THE THERAPEUTIC INDEX ACCEPTABLE, The Journal of pediatrics, 130(1), 1997, pp. 3-4
RANDOMIZED STUDY COMPARING PATIENT-DIRECTED HYPERTENSION MANAGEMENT WITH USUAL OFFICE-BASED CARE
Authors: ZARNKE KB FEAGAN BG MAHON JL FELDMAN RD
Citation: Kb. Zarnke et al., RANDOMIZED STUDY COMPARING PATIENT-DIRECTED HYPERTENSION MANAGEMENT WITH USUAL OFFICE-BASED CARE, Clinical pharmacology and therapeutics, 61(2), 1997, pp. 58-58
DOES SELF-ADMINISTRATION OF A QUALITY-OF-LIFE INDEX FOR INFLAMMATORY BOWEL-DISEASE CHANGE THE RESULTS
Authors: IRVINE EJ FEAGAN BG WONG CJ
Citation: Ej. Irvine et al., DOES SELF-ADMINISTRATION OF A QUALITY-OF-LIFE INDEX FOR INFLAMMATORY BOWEL-DISEASE CHANGE THE RESULTS, Journal of clinical epidemiology, 49(10), 1996, pp. 1177-1185
ORAL BUDESONIDE THERAPY FOR ULCERATIVE-COLITIS - A TOPICAL TALE
Authors: FEAGAN BG
Citation: Bg. Feagan, ORAL BUDESONIDE THERAPY FOR ULCERATIVE-COLITIS - A TOPICAL TALE, Gastroenterology, 110(6), 1996, pp. 2000-2002
INFLAMMATORY BOWEL-DISEASE ON THE INTERNET - ELECTRONIC COMMUNICATIONBETWEEN PATIENTS
Authors: MCDONALD JWD FEAGAN BG GREGOR J
Citation: Jwd. Mcdonald et al., INFLAMMATORY BOWEL-DISEASE ON THE INTERNET - ELECTRONIC COMMUNICATIONBETWEEN PATIENTS, Gastroenterology, 110(4), 1996, pp. 962-962
ORAL BUDESONIDE AS MAINTENANCE TREATMENT FOR CROHNS-DISEASE - A PLACEBO-CONTROLLED, DOSE-RANGING STUDY
Authors: GREENBERG GR FEAGAN BG MARTIN F SUTHERLAND LR THOMSON ABR WILLIAMS N NILSSON LG PERSSON T
Citation: Gr. Greenberg et al., ORAL BUDESONIDE AS MAINTENANCE TREATMENT FOR CROHNS-DISEASE - A PLACEBO-CONTROLLED, DOSE-RANGING STUDY, Gastroenterology, 110(1), 1996, pp. 45-51
THERAPEUTICS AND INFLAMMATORY BOWEL-DISEASE - A GUIDE TO THE INTERPRETATION OF RANDOMIZED CONTROLLED TRIALS
Authors: FEAGAN BG MCDONALD JWD KOVAL JJ
Citation: Bg. Feagan et al., THERAPEUTICS AND INFLAMMATORY BOWEL-DISEASE - A GUIDE TO THE INTERPRETATION OF RANDOMIZED CONTROLLED TRIALS, Gastroenterology, 110(1), 1996, pp. 275-283
ETHICS OF N-OF-1 TRIALS
Authors: MAHON JL FEAGAN BG LAUPACIS A
Citation: Jl. Mahon et al., ETHICS OF N-OF-1 TRIALS, Lancet, 345(8955), 1995, pp. 989-989
METHOTREXATE FOR CROHNS-DISEASE - REPLY
Authors: FEAGAN BG MCDONALD JWD
Citation: Bg. Feagan et Jwd. Mcdonald, METHOTREXATE FOR CROHNS-DISEASE - REPLY, The New England journal of medicine, 333(9), 1995, pp. 601-601
METHOTREXATE FOR THE TREATMENT OF CROHNS-DISEASE
Authors: FEAGAN BG ROCHON J FEDORAK RN IRVINE EJ WILD G SUTHERLAND L STEINHART AH GREENBERG GR GILLIES R HOPKINS M HANAUER SB MCDONALD JWD
Citation: Bg. Feagan et al., METHOTREXATE FOR THE TREATMENT OF CROHNS-DISEASE, The New England journal of medicine, 332(5), 1995, pp. 292-297
ORAL BUDESONIDE AS MAINTENANCE TREATMENT FOR CROHNS-DISEASE
Authors: GREENBERG GR FEAGAN BG MARTIN F SUTHERLAND LR THOMSON ABR WILLIAMS CN NILSSON LG PERSSON T
Citation: Gr. Greenberg et al., ORAL BUDESONIDE AS MAINTENANCE TREATMENT FOR CROHNS-DISEASE, Gastroenterology, 108(4), 1995, pp. 827-827
ORAL BUDESONIDE FOR ACTIVE CROHNS-DISEASE
Authors: GREENBERG GR FEAGAN BG MARTIN F SUTHERLAND LR THOMSON ABR WILLIAMS CR NILSSON LG PERSSON T BAIN V CHERRY R FEDORAK R LALOR E SHERBANIUK R YACYSHYN B KIERDEKIS P BAILEY R MEYER D FREEMAN H DAWS P HOLLAND S BUYTENDORP M WHITTAKER S CHANG A SUTHERLAND L HERSHFIELD N MACCANNELL K MEDDING J PRICE L SHAFFER E RACICOT N BASS S BRIDGES R BLUSTEIN P LAY T VANROSENDAAL G WATSON M WILLIAMS CN VANZANTEN V LEDDIN D FALKENHAM J TANTON R HUMAN P TURNBALL G SCHEP G WOOLNOUGH J DALLAIRE C ROSSEAU B BERNARD F DUBE R PARE P MORIN A LAFRANCE D LICHTER J POLESKI M CLELAND D DALY D WILD G FINENBINE S BELLIVEAU P DAUPHINEE W MISKIN S SUTHERLAND H BARBER C IRVINE J COLLINS S CROITORU K HUNT R SALINA S DONNELLY M BAKER S ALVI A ARCHAMBAULT A JOBIN G TROUVE ML GAGNON M GILLIES R CHAMPION M MACINTOSH D PATEL D SEKAR A THOMPSON W FITZGERALD R WOROBETZ L OSACHOFF J MCHATTIE J EDWARDS J STEINHART H SLATER A BAKER J JEEJEEBHOY KN MCDERMOTT G SAIBIL F COHEN L PEARAN S WOLMAN SL HABAL F STAFFORD S BARNETT W BONDY D MCDONALD J HOPKINS MB HOWARD J BELSHEIM M PONICH T WATSON W GILMORE P REYNOLDS R LLOYD D PROKOPIW I MOYER L VONWESTARP C SHUMAK SL REDDY SSK BELANGER R GEORGE SR SEIDEGARD C PERSSON T
Citation: Gr. Greenberg et al., ORAL BUDESONIDE FOR ACTIVE CROHNS-DISEASE, The New England journal of medicine, 331(13), 1994, pp. 836-841
LOW-DOSE CYCLOSPORINE FOR THE TREATMENT OF CROHNS-DISEASE
Authors: FEAGAN BG MCDONALD JWD ROCHON J LAUPACIS A FEDORAK RN KINNEAR D SAIBIL F GROLL A ARCHAMBAULT A GILLIES R VALBERG B IRVINE EJ
Citation: Bg. Feagan et al., LOW-DOSE CYCLOSPORINE FOR THE TREATMENT OF CROHNS-DISEASE, The New England journal of medicine, 330(26), 1994, pp. 1846-1851
Risultati: 1-24 |